INS and Sepsis: Inflammation-insulin resistance crosstalk and altered innate immunity in MASLD may amplify cholestatic responses to sepsis, hypoperfusion, and parenteral/enteral nutrition—typical ICU exposures—without necessarily increasing hepatocellular injury rates at 72 h.